Literature DB >> 22687243

Diverse regulation of AKT and GSK-3β by O-GlcNAcylation in various types of cells.

Jianhua Shi1, Shiliang Wu, Chun-ling Dai, Yi Li, Inge Grundke-Iqbal, Khalid Iqbal, Fei Liu, Cheng-Xin Gong.   

Abstract

Protein kinase B (AKT) and glycogen synthase kinase-3β (GSK-3β) are major components of insulin-AKT signaling that plays crucial roles in various types of tissue. Recent studies found that these two kinases are modified posttranslationally by O-GlcNAcylation. Here, we demonstrate that O-GlcNAcylation regulated phosphorylation/activation of AKT and GSK-3β in different manners in kidney HEK-293FT cells, but did not affect these two kinases in hepatic HepG2 cells. In neuronal cells, O-GlcNAcylation regulated phosphorylation of AKT negatively, but had no effect on GSK-3β. These results suggest protein-specific and cell type-specific regulation of AKT and GSK-3β by O-GlcNAcylation. Therefore, studies on the roles of AKT and GSK-3β O-GlcNAcylation should be done in a tissue- and cell type-specific manner.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22687243      PMCID: PMC3407308          DOI: 10.1016/j.febslet.2012.05.063

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  30 in total

1.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.

Authors:  Keith Vosseller; Lance Wells; M Daniel Lane; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

Authors:  Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Gerald W Hart; Cheng-Xin Gong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

3.  Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.

Authors:  Fei Liu; Jianhua Shi; Hitoshi Tanimukai; Jinhua Gu; Jianlan Gu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  Brain       Date:  2009-05-18       Impact factor: 13.501

4.  O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.

Authors:  Eun-Sil Kang; Dohyun Han; Jungeun Park; Tae Kyoung Kwak; Min-A Oh; Sin-Ae Lee; Suyong Choi; Zee Yong Park; Youngsoo Kim; Jung Weon Lee
Journal:  Exp Cell Res       Date:  2008-05-09       Impact factor: 3.905

Review 5.  Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies.

Authors:  Kyriaki Gerozissis
Journal:  Eur J Pharmacol       Date:  2008-02-29       Impact factor: 4.432

6.  Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells.

Authors:  Bai Luo; Yudi Soesanto; Donald A McClain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-03       Impact factor: 8.311

7.  Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease.

Authors:  Ying Liu; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  J Neurochem       Date:  2009-07-31       Impact factor: 5.372

8.  Regulation of Akt signaling by O-GlcNAc in euglycemia.

Authors:  Yudi A Soesanto; Bai Luo; Deborah Jones; Rodrick Taylor; J Scott Gabrielsen; Glendon Parker; Donald A McClain
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-26       Impact factor: 4.310

9.  Hepatic glucose sensing via the CREB coactivator CRTC2.

Authors:  Renaud Dentin; Susan Hedrick; Jianxin Xie; John Yates; Marc Montminy
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

10.  Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance.

Authors:  Xiaoyong Yang; Pat P Ongusaha; Philip D Miles; Joyce C Havstad; Fengxue Zhang; W Venus So; Jeffrey E Kudlow; Robert H Michell; Jerrold M Olefsky; Seth J Field; Ronald M Evans
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

View more
  20 in total

1.  Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition.

Authors:  Ioannis Akoumianakis; Ileana Badi; Gillian Douglas; Surawee Chuaiphichai; Laura Herdman; Nadia Akawi; Marios Margaritis; Alexios S Antonopoulos; Evangelos K Oikonomou; Costas Psarros; Nikolaos Galiatsatos; Dimitris Tousoulis; Attila Kardos; Rana Sayeed; George Krasopoulos; Mario Petrou; Uwe Schwahn; Paulus Wohlfart; Norbert Tennagels; Keith M Channon; Charalambos Antoniades
Journal:  Sci Transl Med       Date:  2020-04-29       Impact factor: 17.956

Review 2.  Too sweet to resist: Control of immune cell function by O-GlcNAcylation.

Authors:  Tristan de Jesus; Sudhanshu Shukla; Parameswaran Ramakrishnan
Journal:  Cell Immunol       Date:  2018-06-02       Impact factor: 4.868

Review 3.  Integrating adipocyte insulin signaling and metabolism in the multi-omics era.

Authors:  C Martinez Calejman; W G Doxsey; D J Fazakerley; D A Guertin
Journal:  Trends Biochem Sci       Date:  2022-03-15       Impact factor: 14.264

4.  Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death.

Authors:  Abhishek Asthana; Parameswaran Ramakrishnan; Yorleny Vicioso; Keman Zhang; Reshmi Parameswaran
Journal:  Mol Cancer Ther       Date:  2018-08-06       Impact factor: 6.261

5.  Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications.

Authors:  Antonieta L Salguero; Maggie Chen; Aaron T Balana; Nam Chu; Hanjie Jiang; Brad A Palanski; Hwan Bae; Katharine M Wright; Sara Nathan; Heng Zhu; Sandra B Gabelli; Matthew R Pratt; Philip A Cole
Journal:  ACS Chem Biol       Date:  2021-12-23       Impact factor: 5.100

6.  Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates.

Authors:  François-Xavier Cantrelle; Anne Loyens; Xavier Trivelli; Oliver Reimann; Clément Despres; Neha S Gandhi; Christian P R Hackenberger; Isabelle Landrieu; Caroline Smet-Nocca
Journal:  Front Mol Neurosci       Date:  2021-06-17       Impact factor: 5.639

Review 7.  O-GlcNAcylation in Hyperglycemic Pregnancies: Impact on Placental Function.

Authors:  Jie Ning; Huixia Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-01       Impact factor: 5.555

8.  O-GlcNAcylation regulates ischemia-induced neuronal apoptosis through AKT signaling.

Authors:  Jianhua Shi; Jin-hua Gu; Chun-ling Dai; Jianlan Gu; Xiaoxia Jin; Jianming Sun; Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

Review 9.  Posttranslational regulation of Akt in human cancer.

Authors:  Chia-Hsin Chan; Ukhyun Jo; Abraham Kohrman; Abdol Hossein Rezaeian; Ping-Chieh Chou; Christopher Logothetis; Hui-Kuan Lin
Journal:  Cell Biosci       Date:  2014-10-01       Impact factor: 7.133

Review 10.  Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.

Authors:  John C Chatham; Jianhua Zhang; Adam R Wende
Journal:  Physiol Rev       Date:  2020-07-30       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.